Profile
Stephane Depil served as the Chief Executive Officer of NETRIS Pharma SAS and as the Medical Director of the Cancer Immunotherapy Program at Centre Léon Bérard Lyon et Rhône-Alpes.
He also worked as the Chief Medical Officer and EVP-Research & Development at Cellectis SA from 2017 to 2019.
Depil holds a doctorate degree from Université de Lille III.
Former positions of Stephane Depil
| Companies | Position | End |
|---|---|---|
| CELLECTIS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2019 |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Chief Executive Officer | - |
Centre Léon Bérard Lyon et Rhône-Alpes | Corporate Officer/Principal | - |
Training of Stephane Depil
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Centre Léon Bérard Lyon et Rhône-Alpes | |
Université de Lille III
Université de Lille III Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Stephane Depil
















